Table 4.

Previously reported superantigen genotypes

Genotype	speA	speC	speG	speH	speI	speJ	speK	speL	speM	ssa	smeZ	Othername	Countries	emm	Year
A (n = 1)	X		X		X				X		X	None
B (n = 17)	X		X								X	R	Australia	1	2001-2002 [6]
												A	Sweden	1	1989 [15]
C (n = 1)	X		X			X				X	X	F	Australia	1	2001-2001 [6]
D (n = 7)	X		X			X					X	D	Australia	1	2001-2002 [6]
												C	Sweden	1	1988-2001 [15]
												Not Given	Norway	1	2006-2007 [16]
												Not Given	New Zealand	1	Not given [17]
												Not Given	Spain	1	1999-2003 [18]
												I	Norway	1	1988-2003 [19]
												Not Given	Sweden	1	2006-2007 [20]
E (n = 3)	X		X		X						X	None
F (n = 1)	X		X		X	X					X	None
G (n = 1)			X	X	X				X		X	None
H (n = 2)		X	X	X	X					X	X	D	China	1	2005-2006 [21]
												D	China	12	1993-1994, 2005-2006 [21]
J (n = 19)		X	X	X	X						X	H	Australia	12	2001-2002 [6]
												S3	Sweden	12	1989-1993 [15]
												Not Given	Norway	12	2006-2007 [16]
												Not Given	Spain	12	1999-2003 [18]
												VII	Norway	12	1988-2003 [19]
												S26	Sweden	66	1989 [15]
K (n = 3)		X	X								X	None
M (n = 2)		X	X	X	X				X		X	None
N (n = 8)			X	X	X						X	J	Australia	12	2001-2002 [6]
												Not Given	Norway	12	2006-2007 [16]
												Not Given	Spain	12	1999-2003 [18]
												AC	Sweden	66	1988-1990 [15]
O (n = 1)	X	X	X	X	X						X	None
P (n = 1)			X								X	None
Q (n = 4)		X	X		X						X	None
R (n = 1)		X	X	X	X	X					X	Not Given	ATCC	1	Not given [17]
S (n = 1)		X	X		X					X	X	None
T (n = 1)			X	X	X	X						Not Given	New Zealand	12	Not given [17]
U (n = 2)			X	X	X					X	X	T	Australia	12	2001-2002 [6]
												Not Given	Spain	12	1999-2003 [18]
V (n = 1)	X		X	X	X						X	None

Previously published emm 1, 12 and 66 superantigen genotypes were reviewed and compared to our collection. “Genotype” refers to designations given in this paper. “Other name” refers to pattern name given in previously published work. Citations refer to the reference section.